Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    gastroenterology

    Autoimmune atrophic gastritis

    Also known as: Autoimmune gastritis, Autoimmune metaplastic atrophic gastritis, Type A gastritis, Autoimmune corpus-predominant atrophic gastritis

    Autoimmune atrophic gastritis is an immune-mediated disorder characterised by the destruction of gastric parietal cells, causing corpus-predominant atrophy, reduced acid secretion, and secondary hypergastrinaemia. Clinical assessment prioritises evaluation for iron and vitamin B12 deficiencies, including pernicious anaemia, with replacement therapy as indicated. Gastroenterology follow-up addresses diagnostic confirmation, Helicobacter pylori status, and individualised surveillance, particularly for type I gastric neuroendocrine tumours and associated lesions, noting that adenocarcinoma risk varies with accompanying risk factors. Chinese-medicine assessment may provide an adjunctive framework for dyspepsia, appetite disturbance, and wellbeing, but the supplied records contain no clinical efficacy evidence for acupuncture or herbal medicine in this condition. Neither modality should be represented as reversing autoimmunity, restoring parietal cells, or preventing cancer.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain regular meal timing and titrate portion sizes according to individual tolerance, avoiding restrictive exclusion diets.
    • •Maintain a concise record of symptoms, dietary tolerance, weight stability, and adherence to prescribed supplementation for clinical review.
    • •Minimise alcohol consumption and cease tobacco use; patients should be referred for smoking cessation support if required.
    • •Ensure adherence to all scheduled pathology tests, specialist consultations, and endoscopic surveillance, regardless of symptomatic status.

    Cautions & Contraindications

    See sources
    • •Do not substitute acupuncture or herbs for investigation of gastric lesions or individualised endoscopic surveillance. Symptom relief does not demonstrate reduced neuroendocrine tumour or adenocarcinoma risk.[]
    • •Do not interpret fatigue or pallor solely as qi or blood deficiency, or delay medically indicated iron or vitamin B12 assessment and replacement. The supplied case report and genetic study are contextual, not replacement-treatment guidelines.[,]
    • •Coexisting autoimmune liver, bowel or thyroid disease requires coordinated medical and medication review before herbal prescribing. The supplied single case illustrates possible coexistence, not its frequency or the safety of any formula.[]

    When to reassess or seek care again

    See sources

    Review adjunctive care after 2–4 weeks, using a 0–10 discomfort score, weekly nausea/fullness frequency, meal tolerance, weight and adverse effects. Coordinate blood count, ferritin and vitamin B12 follow-up with the treating clinician rather than setting an independent testing schedule. Stop or revise adjunctive treatment if there is no meaningful improvement by 4 weeks; refer earlier for worsening symptoms, weight loss, neurological symptoms or suspected deficiency. Do not change surveillance intervals on the basis of symptom response.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Journal of inflammation research · 2025
    2. QJM : monthly journal of the Association of Physicians · 2025
    3. Frontiers in immunology · 2026
    4. BMC cancer · 2024

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.